Novo’s pill for kids; Altimmune’s $225M offering; Merck teams with Google Cloudnews2026-04-23T14:27:09+00:00April 23rd, 2026|Endpoints News|
Amneal to buy a biosimilar company; Samsung Bio workers protestnews2026-04-23T14:00:25+00:00April 23rd, 2026|Endpoints News|
Endpoints wins Neal Awards for Trump and gene editing coverage, JPM eventnews2026-04-23T12:55:53+00:00April 23rd, 2026|Endpoints News|
Gravity Rail raises $2.75M from Redesign Health for AI patient communicationnews2026-04-23T11:00:51+00:00April 23rd, 2026|Endpoints News|
Roche says its investigational breast cancer pill could outsell Herceptinnews2026-04-23T10:47:53+00:00April 23rd, 2026|Endpoints News|
Sanofi defends Garijo appointment, says it is ‘fully committed’ to immunologynews2026-04-23T09:00:47+00:00April 23rd, 2026|Endpoints News|
OpenAI’s head of health lays out the AI giant’s healthcare ambitionsnews2026-04-22T20:00:38+00:00April 22nd, 2026|Endpoints News|
AbbVie’s North Carolina $1.4B manufacturing site to finish during Trump’s termnews2026-04-22T18:38:54+00:00April 22nd, 2026|Endpoints News|
BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS worknews2026-04-22T17:40:04+00:00April 22nd, 2026|Endpoints News|
Pharma-backed petition calls on FDA to reform release of drug rejection lettersnews2026-04-22T16:14:47+00:00April 22nd, 2026|Endpoints News|
